Loading...
Cefpodoxime 200 mg+ Clavulanic Acid 125mg
A high-potency, synergistic antibiotic combination. EXLLA-CV 325 pairs the broad-spectrum action of Cefpodoxime with Clavulanic Acid to overcome bacterial resistance, ensuring a 100% success rate in treating complicated respiratory and urinary tract infections.
A high-potency, synergistic antibiotic combination. EXLLA-CV 325 pairs the broad-spectrum action of Cefpodoxime with Clavulanic Acid to overcome bacterial resistance, ensuring a 100% success rate in treating complicated respiratory and urinary tract infections.
Many bacteria produce an enzyme called "Beta-Lactamase" that destroys antibiotics before they can work. Clavulanic Acid (125mg) acts as a "Suicide Inhibitor"—it binds to and permanently deactivates these enzymes, clearing the path for the antibiotic to strike.
Cefpodoxime (200mg) then moves in to inhibit the synthesis of the bacterial cell wall. Without a wall, the bacteria lose their internal pressure and burst (lysis), leading to rapid clearance of the infection.
This combination is exceptionally effective against both Gram-positive and Gram-negative pathogens, including "tough" strains of Str...
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
